Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway. [electronic resource]
Producer: 20141117Description: 1400-9 p. digitalISSN:- 1532-1827
- Antineoplastic Agents, Alkylating -- pharmacology
- Brain Neoplasms -- drug therapy
- Cell Line, Tumor
- Cell Proliferation
- Dacarbazine -- analogs & derivatives
- Drug Resistance, Neoplasm
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Gene Expression
- Glioma -- drug therapy
- Humans
- Insulin-Like Growth Factor Binding Protein 2 -- physiology
- Integrin beta1 -- metabolism
- MAP Kinase Signaling System
- Neoplasm Invasiveness
- Temozolomide
- Tissue Array Analysis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.